Cargando…

Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease

Recent studies have suggested that the clinical features of elderly-onset adult-onset Still’s disease (AOSD) differ from those of young and middle-aged-onset patients, whereas the details remain unclear, and cytokine profiles of elderly-onset AOSD have not been reported. To clarify the clinical feat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagishita, Mizuki, Tsuboi, Hiroto, Kuroda, Yuki, Sawabe, Tomonori, Kawashima, Akira, Kawashima, Fumina, Uematsu, Nana, Sato, Ryota, Nishiyama, Taihei, Terasaki, Mayu, Toko, Hirofumi, Honda, Fumika, Ohyama, Ayako, Abe, Saori, Kitada, Ayako, Miki, Haruka, Hagiwara, Shinya, Kondo, Yuya, Sumida, Takayuki, Matsumoto, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734186/
https://www.ncbi.nlm.nih.gov/pubmed/36494453
http://dx.doi.org/10.1038/s41598-022-25514-6
_version_ 1784846536050475008
author Yagishita, Mizuki
Tsuboi, Hiroto
Kuroda, Yuki
Sawabe, Tomonori
Kawashima, Akira
Kawashima, Fumina
Uematsu, Nana
Sato, Ryota
Nishiyama, Taihei
Terasaki, Mayu
Toko, Hirofumi
Honda, Fumika
Ohyama, Ayako
Abe, Saori
Kitada, Ayako
Miki, Haruka
Hagiwara, Shinya
Kondo, Yuya
Sumida, Takayuki
Matsumoto, Isao
author_facet Yagishita, Mizuki
Tsuboi, Hiroto
Kuroda, Yuki
Sawabe, Tomonori
Kawashima, Akira
Kawashima, Fumina
Uematsu, Nana
Sato, Ryota
Nishiyama, Taihei
Terasaki, Mayu
Toko, Hirofumi
Honda, Fumika
Ohyama, Ayako
Abe, Saori
Kitada, Ayako
Miki, Haruka
Hagiwara, Shinya
Kondo, Yuya
Sumida, Takayuki
Matsumoto, Isao
author_sort Yagishita, Mizuki
collection PubMed
description Recent studies have suggested that the clinical features of elderly-onset adult-onset Still’s disease (AOSD) differ from those of young and middle-aged-onset patients, whereas the details remain unclear, and cytokine profiles of elderly-onset AOSD have not been reported. To clarify the clinical features and cytokine profiles of elderly-onset AOSD, we examined patients with AOSD who developed the disease between January 2006 and September 2021. We divided the patients into the young and middle-aged-onset group (aged < 65 years) and the elderly-onset group (aged ≥ 65 years) and compared the groups in terms of patient characteristics, clinical symptoms, laboratory findings including serum interleukin (IL)-6 and IL-18, treatment, and prognosis. A total of 48 patients were examined (10 in the elderly-onset group). In the elderly-onset group, atypical rash was significantly more frequent, typical rash and splenomegaly were significantly less frequent, white blood cell count and neutrophil ratio were significantly higher and serum IL-6 levels were significantly lower. Serum IL-6 showed a significantly negative correlation with age at onset. Treatment and relapse were comparable between the 2 groups, whereas infections were significantly more frequent in the elderly-onset group. The clinical features and cytokine profiles of elderly-onset AOSD might differ from those of young and middle-aged-onset AOSD.
format Online
Article
Text
id pubmed-9734186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97341862022-12-11 Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease Yagishita, Mizuki Tsuboi, Hiroto Kuroda, Yuki Sawabe, Tomonori Kawashima, Akira Kawashima, Fumina Uematsu, Nana Sato, Ryota Nishiyama, Taihei Terasaki, Mayu Toko, Hirofumi Honda, Fumika Ohyama, Ayako Abe, Saori Kitada, Ayako Miki, Haruka Hagiwara, Shinya Kondo, Yuya Sumida, Takayuki Matsumoto, Isao Sci Rep Article Recent studies have suggested that the clinical features of elderly-onset adult-onset Still’s disease (AOSD) differ from those of young and middle-aged-onset patients, whereas the details remain unclear, and cytokine profiles of elderly-onset AOSD have not been reported. To clarify the clinical features and cytokine profiles of elderly-onset AOSD, we examined patients with AOSD who developed the disease between January 2006 and September 2021. We divided the patients into the young and middle-aged-onset group (aged < 65 years) and the elderly-onset group (aged ≥ 65 years) and compared the groups in terms of patient characteristics, clinical symptoms, laboratory findings including serum interleukin (IL)-6 and IL-18, treatment, and prognosis. A total of 48 patients were examined (10 in the elderly-onset group). In the elderly-onset group, atypical rash was significantly more frequent, typical rash and splenomegaly were significantly less frequent, white blood cell count and neutrophil ratio were significantly higher and serum IL-6 levels were significantly lower. Serum IL-6 showed a significantly negative correlation with age at onset. Treatment and relapse were comparable between the 2 groups, whereas infections were significantly more frequent in the elderly-onset group. The clinical features and cytokine profiles of elderly-onset AOSD might differ from those of young and middle-aged-onset AOSD. Nature Publishing Group UK 2022-12-09 /pmc/articles/PMC9734186/ /pubmed/36494453 http://dx.doi.org/10.1038/s41598-022-25514-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yagishita, Mizuki
Tsuboi, Hiroto
Kuroda, Yuki
Sawabe, Tomonori
Kawashima, Akira
Kawashima, Fumina
Uematsu, Nana
Sato, Ryota
Nishiyama, Taihei
Terasaki, Mayu
Toko, Hirofumi
Honda, Fumika
Ohyama, Ayako
Abe, Saori
Kitada, Ayako
Miki, Haruka
Hagiwara, Shinya
Kondo, Yuya
Sumida, Takayuki
Matsumoto, Isao
Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
title Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
title_full Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
title_fullStr Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
title_full_unstemmed Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
title_short Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
title_sort clinical features and serum cytokine profiles of elderly-onset adult-onset still’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734186/
https://www.ncbi.nlm.nih.gov/pubmed/36494453
http://dx.doi.org/10.1038/s41598-022-25514-6
work_keys_str_mv AT yagishitamizuki clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT tsuboihiroto clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT kurodayuki clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT sawabetomonori clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT kawashimaakira clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT kawashimafumina clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT uematsunana clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT satoryota clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT nishiyamataihei clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT terasakimayu clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT tokohirofumi clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT hondafumika clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT ohyamaayako clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT abesaori clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT kitadaayako clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT mikiharuka clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT hagiwarashinya clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT kondoyuya clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT sumidatakayuki clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease
AT matsumotoisao clinicalfeaturesandserumcytokineprofilesofelderlyonsetadultonsetstillsdisease